Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry

Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra‐cellularly via the phosphorylation of gemcitabine by deoxycytidine kinase. The monitoring of dFdCTP in human peripheral blood mononuclear cells (PBMCs), in addition to plasma concentrations of gemcitab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of mass spectrometry. 2006-12, Vol.41 (12), p.1633-1642
Hauptverfasser: Veltkamp, S. A., Hillebrand, M. J. X., Rosing, H., Jansen, R. S., Wickremsinhe, E. R., Perkins, E. J., Schellens, J. H. M., Beijnen, J. H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1642
container_issue 12
container_start_page 1633
container_title Journal of mass spectrometry.
container_volume 41
creator Veltkamp, S. A.
Hillebrand, M. J. X.
Rosing, H.
Jansen, R. S.
Wickremsinhe, E. R.
Perkins, E. J.
Schellens, J. H. M.
Beijnen, J. H.
description Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra‐cellularly via the phosphorylation of gemcitabine by deoxycytidine kinase. The monitoring of dFdCTP in human peripheral blood mononuclear cells (PBMCs), in addition to plasma concentrations of gemcitabine and its metabolite 2′,2′‐difluorodeoxyuridine, is considered very useful in determining pharmacokinetic–pharmacodynamic relationships. We describe a novel sensitive assay for the quantification of dFdCTP in human PBMCs. The method is based on weak anion‐exchange liquid chromatography and detection with tandem mass spectrometry (LC‐MS/MS). The assay has been validated from 1 ng/ml (lower limit of quantification, LLOQ) to 25 ng/ml (upper limit of quantification, ULOQ) using 180 µl aliquots of PBMC extracts containing ∼0.648 mg protein or 3.8 × 106 lysed PBMCs. The LLOQ is equivalent to 94 fmol/106 cells (1 ng/ml = 0.18 ng/180 µl or 0.18 ng/0.648 mg protein = 0.047 ng/106 cells or 94 fmol/106 cells). This highly sensitive assay is capable of quantifying about 200‐fold lower concentrations of dFdCTP in human PBMCs than currently available methods. Copyright © 2006 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/jms.1133
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19483598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19483598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4183-796835a2c13800fb24210213c628e466dd7f6c0e7af6d1b0e749dc57fcc70f583</originalsourceid><addsrcrecordid>eNp10c1u1DAUBeAIgWgpSDwB8gbEJsWOM4mzRKP-UBUQAgQ768a5mbh17NR2mOa5-oIkmoiuWPnK-nyPrJMkrxk9ZZRmH276cMoY50-SY0arIq2EEE-XuSzSDSvzo-RFCDeU0qrKi-fJESsZK3mZHScP30awUUeI-g8SsGCmoANxLdlhr-b7Wlsk0euhc2HoICLRlnRjD5YMuFyjB0Nq41xDemedHZVB8EShMYGMQdsd2SPczru1syneqw7sDonRd6NuiOq86yG6nYehm4hy42CwIXsdOxLBNtiTHkIgYUAVZ4rRTy-TZy2YgK_W8yT5eX72Y3uZXn-9-LT9eJ2qnAmellUh-AYyxbigtK2zPGM0Y1wVmcC8KJqmbAtFsYS2aFg9D3nVqE3ZKlXSdiP4SfLusHfw7m7EEGWvw_IvsOjGIFmVzwHVAt8foPIuBI-tHLzuwU-SUbkUJOeC5FLQTN-sO8e6x-YRro3M4O0KICgwrQerdHh0gudC8MWlB7fXBqf_Bsqrz9_X4NXrEPH-nwd_K4s5eCN_fbmQ299XojqfX1X8L2TGu2Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19483598</pqid></control><display><type>article</type><title>Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Veltkamp, S. A. ; Hillebrand, M. J. X. ; Rosing, H. ; Jansen, R. S. ; Wickremsinhe, E. R. ; Perkins, E. J. ; Schellens, J. H. M. ; Beijnen, J. H.</creator><creatorcontrib>Veltkamp, S. A. ; Hillebrand, M. J. X. ; Rosing, H. ; Jansen, R. S. ; Wickremsinhe, E. R. ; Perkins, E. J. ; Schellens, J. H. M. ; Beijnen, J. H.</creatorcontrib><description>Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra‐cellularly via the phosphorylation of gemcitabine by deoxycytidine kinase. The monitoring of dFdCTP in human peripheral blood mononuclear cells (PBMCs), in addition to plasma concentrations of gemcitabine and its metabolite 2′,2′‐difluorodeoxyuridine, is considered very useful in determining pharmacokinetic–pharmacodynamic relationships. We describe a novel sensitive assay for the quantification of dFdCTP in human PBMCs. The method is based on weak anion‐exchange liquid chromatography and detection with tandem mass spectrometry (LC‐MS/MS). The assay has been validated from 1 ng/ml (lower limit of quantification, LLOQ) to 25 ng/ml (upper limit of quantification, ULOQ) using 180 µl aliquots of PBMC extracts containing ∼0.648 mg protein or 3.8 × 106 lysed PBMCs. The LLOQ is equivalent to 94 fmol/106 cells (1 ng/ml = 0.18 ng/180 µl or 0.18 ng/0.648 mg protein = 0.047 ng/106 cells or 94 fmol/106 cells). This highly sensitive assay is capable of quantifying about 200‐fold lower concentrations of dFdCTP in human PBMCs than currently available methods. Copyright © 2006 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 1076-5174</identifier><identifier>EISSN: 1096-9888</identifier><identifier>DOI: 10.1002/jms.1133</identifier><identifier>PMID: 17117372</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Analysis ; Anions ; Antimetabolites, Antineoplastic - analysis ; Antimetabolites, Antineoplastic - chemistry ; Antimetabolites, Antineoplastic - pharmacokinetics ; Antineoplastic agents ; Biological and medical sciences ; Calibration ; Chromatography, Liquid - methods ; Chromatography, Liquid - standards ; Deoxycytidine - analogs &amp; derivatives ; Deoxycytidine - analysis ; Deoxycytidine - chemistry ; Deoxycytidine - pharmacokinetics ; dFdCTP ; General aspects ; General pharmacology ; Humans ; intra-cellular ; LC-MS/MS ; Leukocyte Count ; Leukocytes, Mononuclear - metabolism ; Medical sciences ; PBMCs ; Pharmacology. Drug treatments ; Proteins - analysis ; Reproducibility of Results ; Sensitivity and Specificity ; Tandem Mass Spectrometry - methods ; Tandem Mass Spectrometry - standards ; validation</subject><ispartof>Journal of mass spectrometry., 2006-12, Vol.41 (12), p.1633-1642</ispartof><rights>Copyright © 2006 John Wiley &amp; Sons, Ltd.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4183-796835a2c13800fb24210213c628e466dd7f6c0e7af6d1b0e749dc57fcc70f583</citedby><cites>FETCH-LOGICAL-c4183-796835a2c13800fb24210213c628e466dd7f6c0e7af6d1b0e749dc57fcc70f583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjms.1133$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjms.1133$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18348832$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17117372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Veltkamp, S. A.</creatorcontrib><creatorcontrib>Hillebrand, M. J. X.</creatorcontrib><creatorcontrib>Rosing, H.</creatorcontrib><creatorcontrib>Jansen, R. S.</creatorcontrib><creatorcontrib>Wickremsinhe, E. R.</creatorcontrib><creatorcontrib>Perkins, E. J.</creatorcontrib><creatorcontrib>Schellens, J. H. M.</creatorcontrib><creatorcontrib>Beijnen, J. H.</creatorcontrib><title>Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry</title><title>Journal of mass spectrometry.</title><addtitle>J. Mass Spectrom</addtitle><description>Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra‐cellularly via the phosphorylation of gemcitabine by deoxycytidine kinase. The monitoring of dFdCTP in human peripheral blood mononuclear cells (PBMCs), in addition to plasma concentrations of gemcitabine and its metabolite 2′,2′‐difluorodeoxyuridine, is considered very useful in determining pharmacokinetic–pharmacodynamic relationships. We describe a novel sensitive assay for the quantification of dFdCTP in human PBMCs. The method is based on weak anion‐exchange liquid chromatography and detection with tandem mass spectrometry (LC‐MS/MS). The assay has been validated from 1 ng/ml (lower limit of quantification, LLOQ) to 25 ng/ml (upper limit of quantification, ULOQ) using 180 µl aliquots of PBMC extracts containing ∼0.648 mg protein or 3.8 × 106 lysed PBMCs. The LLOQ is equivalent to 94 fmol/106 cells (1 ng/ml = 0.18 ng/180 µl or 0.18 ng/0.648 mg protein = 0.047 ng/106 cells or 94 fmol/106 cells). This highly sensitive assay is capable of quantifying about 200‐fold lower concentrations of dFdCTP in human PBMCs than currently available methods. Copyright © 2006 John Wiley &amp; Sons, Ltd.</description><subject>Analysis</subject><subject>Anions</subject><subject>Antimetabolites, Antineoplastic - analysis</subject><subject>Antimetabolites, Antineoplastic - chemistry</subject><subject>Antimetabolites, Antineoplastic - pharmacokinetics</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Calibration</subject><subject>Chromatography, Liquid - methods</subject><subject>Chromatography, Liquid - standards</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Deoxycytidine - analysis</subject><subject>Deoxycytidine - chemistry</subject><subject>Deoxycytidine - pharmacokinetics</subject><subject>dFdCTP</subject><subject>General aspects</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>intra-cellular</subject><subject>LC-MS/MS</subject><subject>Leukocyte Count</subject><subject>Leukocytes, Mononuclear - metabolism</subject><subject>Medical sciences</subject><subject>PBMCs</subject><subject>Pharmacology. Drug treatments</subject><subject>Proteins - analysis</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Tandem Mass Spectrometry - methods</subject><subject>Tandem Mass Spectrometry - standards</subject><subject>validation</subject><issn>1076-5174</issn><issn>1096-9888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10c1u1DAUBeAIgWgpSDwB8gbEJsWOM4mzRKP-UBUQAgQ768a5mbh17NR2mOa5-oIkmoiuWPnK-nyPrJMkrxk9ZZRmH276cMoY50-SY0arIq2EEE-XuSzSDSvzo-RFCDeU0qrKi-fJESsZK3mZHScP30awUUeI-g8SsGCmoANxLdlhr-b7Wlsk0euhc2HoICLRlnRjD5YMuFyjB0Nq41xDemedHZVB8EShMYGMQdsd2SPczru1syneqw7sDonRd6NuiOq86yG6nYehm4hy42CwIXsdOxLBNtiTHkIgYUAVZ4rRTy-TZy2YgK_W8yT5eX72Y3uZXn-9-LT9eJ2qnAmellUh-AYyxbigtK2zPGM0Y1wVmcC8KJqmbAtFsYS2aFg9D3nVqE3ZKlXSdiP4SfLusHfw7m7EEGWvw_IvsOjGIFmVzwHVAt8foPIuBI-tHLzuwU-SUbkUJOeC5FLQTN-sO8e6x-YRro3M4O0KICgwrQerdHh0gudC8MWlB7fXBqf_Bsqrz9_X4NXrEPH-nwd_K4s5eCN_fbmQ299XojqfX1X8L2TGu2Q</recordid><startdate>200612</startdate><enddate>200612</enddate><creator>Veltkamp, S. A.</creator><creator>Hillebrand, M. J. X.</creator><creator>Rosing, H.</creator><creator>Jansen, R. S.</creator><creator>Wickremsinhe, E. R.</creator><creator>Perkins, E. J.</creator><creator>Schellens, J. H. M.</creator><creator>Beijnen, J. H.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200612</creationdate><title>Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry</title><author>Veltkamp, S. A. ; Hillebrand, M. J. X. ; Rosing, H. ; Jansen, R. S. ; Wickremsinhe, E. R. ; Perkins, E. J. ; Schellens, J. H. M. ; Beijnen, J. H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4183-796835a2c13800fb24210213c628e466dd7f6c0e7af6d1b0e749dc57fcc70f583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Analysis</topic><topic>Anions</topic><topic>Antimetabolites, Antineoplastic - analysis</topic><topic>Antimetabolites, Antineoplastic - chemistry</topic><topic>Antimetabolites, Antineoplastic - pharmacokinetics</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Calibration</topic><topic>Chromatography, Liquid - methods</topic><topic>Chromatography, Liquid - standards</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Deoxycytidine - analysis</topic><topic>Deoxycytidine - chemistry</topic><topic>Deoxycytidine - pharmacokinetics</topic><topic>dFdCTP</topic><topic>General aspects</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>intra-cellular</topic><topic>LC-MS/MS</topic><topic>Leukocyte Count</topic><topic>Leukocytes, Mononuclear - metabolism</topic><topic>Medical sciences</topic><topic>PBMCs</topic><topic>Pharmacology. Drug treatments</topic><topic>Proteins - analysis</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Tandem Mass Spectrometry - methods</topic><topic>Tandem Mass Spectrometry - standards</topic><topic>validation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veltkamp, S. A.</creatorcontrib><creatorcontrib>Hillebrand, M. J. X.</creatorcontrib><creatorcontrib>Rosing, H.</creatorcontrib><creatorcontrib>Jansen, R. S.</creatorcontrib><creatorcontrib>Wickremsinhe, E. R.</creatorcontrib><creatorcontrib>Perkins, E. J.</creatorcontrib><creatorcontrib>Schellens, J. H. M.</creatorcontrib><creatorcontrib>Beijnen, J. H.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of mass spectrometry.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veltkamp, S. A.</au><au>Hillebrand, M. J. X.</au><au>Rosing, H.</au><au>Jansen, R. S.</au><au>Wickremsinhe, E. R.</au><au>Perkins, E. J.</au><au>Schellens, J. H. M.</au><au>Beijnen, J. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry</atitle><jtitle>Journal of mass spectrometry.</jtitle><addtitle>J. Mass Spectrom</addtitle><date>2006-12</date><risdate>2006</risdate><volume>41</volume><issue>12</issue><spage>1633</spage><epage>1642</epage><pages>1633-1642</pages><issn>1076-5174</issn><eissn>1096-9888</eissn><abstract>Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra‐cellularly via the phosphorylation of gemcitabine by deoxycytidine kinase. The monitoring of dFdCTP in human peripheral blood mononuclear cells (PBMCs), in addition to plasma concentrations of gemcitabine and its metabolite 2′,2′‐difluorodeoxyuridine, is considered very useful in determining pharmacokinetic–pharmacodynamic relationships. We describe a novel sensitive assay for the quantification of dFdCTP in human PBMCs. The method is based on weak anion‐exchange liquid chromatography and detection with tandem mass spectrometry (LC‐MS/MS). The assay has been validated from 1 ng/ml (lower limit of quantification, LLOQ) to 25 ng/ml (upper limit of quantification, ULOQ) using 180 µl aliquots of PBMC extracts containing ∼0.648 mg protein or 3.8 × 106 lysed PBMCs. The LLOQ is equivalent to 94 fmol/106 cells (1 ng/ml = 0.18 ng/180 µl or 0.18 ng/0.648 mg protein = 0.047 ng/106 cells or 94 fmol/106 cells). This highly sensitive assay is capable of quantifying about 200‐fold lower concentrations of dFdCTP in human PBMCs than currently available methods. Copyright © 2006 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>17117372</pmid><doi>10.1002/jms.1133</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-5174
ispartof Journal of mass spectrometry., 2006-12, Vol.41 (12), p.1633-1642
issn 1076-5174
1096-9888
language eng
recordid cdi_proquest_miscellaneous_19483598
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Analysis
Anions
Antimetabolites, Antineoplastic - analysis
Antimetabolites, Antineoplastic - chemistry
Antimetabolites, Antineoplastic - pharmacokinetics
Antineoplastic agents
Biological and medical sciences
Calibration
Chromatography, Liquid - methods
Chromatography, Liquid - standards
Deoxycytidine - analogs & derivatives
Deoxycytidine - analysis
Deoxycytidine - chemistry
Deoxycytidine - pharmacokinetics
dFdCTP
General aspects
General pharmacology
Humans
intra-cellular
LC-MS/MS
Leukocyte Count
Leukocytes, Mononuclear - metabolism
Medical sciences
PBMCs
Pharmacology. Drug treatments
Proteins - analysis
Reproducibility of Results
Sensitivity and Specificity
Tandem Mass Spectrometry - methods
Tandem Mass Spectrometry - standards
validation
title Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A39%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantitative%20analysis%20of%20gemcitabine%20triphosphate%20in%20human%20peripheral%20blood%20mononuclear%20cells%20using%20weak%20anion-exchange%20liquid%20chromatography%20coupled%20with%20tandem%20mass%20spectrometry&rft.jtitle=Journal%20of%20mass%20spectrometry.&rft.au=Veltkamp,%20S.%20A.&rft.date=2006-12&rft.volume=41&rft.issue=12&rft.spage=1633&rft.epage=1642&rft.pages=1633-1642&rft.issn=1076-5174&rft.eissn=1096-9888&rft_id=info:doi/10.1002/jms.1133&rft_dat=%3Cproquest_cross%3E19483598%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19483598&rft_id=info:pmid/17117372&rfr_iscdi=true